The oncology nutrition market is driven by increasing number of cancer patients, improving healthcare infrastructure, and rising awareness. Oncology nutrition is prescribed for a cancer patient undergoing treatment and after treatment to cope up with the side effects of chemotherapy, radiation and medication required during the prolong treatment procedure.
The immunity of a cancer patient is weakened during the treatment, which might make the patient susceptible to infections due to pathogens in regular food items. Thus oncology nutrition is recommended to improve the immune system, maintain low body weight and increase strength required during cancer treatment. This is boosting the growth of the global oncology nutrition market.
North America contributed the largest share to the global oncology nutrition market in 2019 and is anticipated to be the dominating geography during the forecast period. The major attributes towards this dominance is the prevalence of head & neck, lung, prostate, and breast cancer across and increasing number of patients in the United States and Canada. According to American Cancer Society, an estimated 1.8 million new cases would be diagnosed in 2020. Asia Pacific is anticipated to witness lucrative growth of oncology nutrition during the forecast period owing to increasing number of cancer patients, growth of medical tourism, and improving healthcare infrastructure in the region.
The report titled “Oncology Nutrition Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global oncology nutrition market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Nestle reported revenues of USD 95.18 Billion in 2019 and the product segment analysis of the company indicates that Powdered and Liquid Beverages business segment of the company dominated revenue in 2019 with the Americas being the major revenue generating geography.
The global oncology nutrition market is segmented based on cancer type, nutrition type, sales channel, and geography. Based on cancer type, the global oncology nutrition market is segmented into head and neck cancer, stomach and gastrointestinal cancers, liver cancer, prostate cancer, colorectal cancer, pancreatic cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and others. Based on nutrition type, the global oncology nutrition market is segmented into enteral nutrition, and parenteral nutrition. Based on sales channel, the global oncology nutrition market is segmented into hospitals, and pharmacies. The pharmacies are further sub-segmented into, online pharmacies and retail pharmacies. Based on geography, the global oncology nutrition market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Additionally, the study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the oncology nutrition companies. Further, market share of prominent companies in the global oncology nutrition market would also be estimated.
For instance, Nestle operates through seven business divisions namely Powdered and Liquid Beverages, Nutrition and Health Science, PetCare, Milk products and Ice cream, Prepared dishes and cooking aids, Confectionery, and Water. The Oncology nutrition are delivered under Nutrition and Health Science business division of the company with revenue contribution of US$ 15.42 billion in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the oncology nutrition companies. Furthermore, the global oncology nutrition market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
The product portfolio would focus on all the products under the oncology nutrition market business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global oncology nutrition market.
Major players operating the global oncology nutrition market include Abbott, B, Braun Melsungen AG, Danone, Fresenius Kabi AG, Global Health Products, Inc., Hormel Foods Corporation, Mead Johnson & Company, LLC., Meiji Holdings Co., Ltd., Nestle, and Victus among others.
Market Segmentation:
By Cancer type
- head and neck cancer
- stomach and gastrointestinal cancers
- liver cancer
- prostate cancer
- colorectal cancer
- pancreatic cancer
- esophageal cancer
- lung cancer
- breast cancer
- blood cancer
- others
By Nutrition type
- enteral nutrition
- parenteral nutrition
By Sales channel
By Geography
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
